Erik Harris - Insider Trading & Ownership

Entity: Individual
Location: 60 Leveroni Court, Novato, CA
Summary: The estimated net worth of Erik Harris is at least $4.05M dollars as of March 26, 2025. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $3.7M. Erik Harris is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $348K.
All Insider Reports: All Insider Reports

Ownership of Erik Harris

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RARE	Ultragenyx Pharmaceutical Inc.	EVP & Chief Commercial Officer	$3.7M	-$636K	-14.7%	Mar 1, 2025
DNLI	Denali Therapeutics Inc.	Director	$348K			May 31, 2024
INZY	Inozyme Pharma, Inc.	Director				Oct 3, 2024
RZLT	Rezolute, Inc.	Director				Mar 25, 2025

Showing 1 to 4 of 4 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.